Postoperative morphine concentration in infants with or without biliary atresia and its association with hepatic

X Wang1, Z W Qiao, Z J Zhou

  • 1Department of Anesthesiology, Children's Hospital of Fudan University, Shanghai, China.

Anaesthesia
|April 23, 2014
PubMed

Insights

Infants with biliary atresia maintain normal hepatic blood flow through compensatory arterial flow. Postoperative morphine concentrations were similar between infants with and without biliary atresia, with an inverse relation to hepatic perfusion.

Area of Science:

  • Pediatric Surgery
  • Hepatology
  • Pharmacokinetics

Background:

  • Biliary atresia is a severe neonatal liver disease requiring surgical intervention.
  • Hepatic blood flow is critical for drug metabolism and organ function.
  • Understanding drug pharmacokinetics in infants with liver disease is essential for safe and effective treatment.

Purpose of the Study:

  • To compare pre-operative hepatic blood flow in infants with and without biliary atresia.
  • To assess postoperative morphine concentrations in these infant groups.
  • To investigate the relationship between hepatic blood flow and morphine pharmacokinetics.

Main Methods:

  • Magnetic resonance imaging (MRI) was used to assess hepatic blood flow in infants undergoing portoenterostomy (Kasai operation) and controls.
  • Intravenous morphine infusion was administered postoperatively to all infants.
  • Morphine concentrations were measured after 24 hours of infusion.

Main Results:

  • No significant difference in relative hepatic blood flow was observed between infants with and without biliary atresia (p = 0.851).
  • Postoperative morphine concentrations at 24 hours were comparable between the two groups (p = 0.460).
  • A significant inverse regression relationship was found between morphine concentration and the hepatic perfusion index (R(2) = 0.519, p = 0.001).

Conclusions:

  • Infants with biliary atresia demonstrate compensatory increases in hepatic arterial blood flow, maintaining overall hepatic blood flow.
  • Hepatic blood flow does not significantly impact morphine concentrations in the early postoperative period in this cohort.
  • The findings suggest that hepatic perfusion plays a role in morphine disposition, warranting further investigation.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382